The Alberta stroke program early ct score in clinical practice: What have we learned?

International Journal of Stroke

Volumn 4, Issue 5, 2009, Pages 354-364

  Puetz, V ^b   Dzialowski, I ^b   Hill, M D ^b   Demchuk, A M ^a,b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acute stroke therapy; CT scan; Ischaemic stroke; Methodology; RtPA; Therapy; Thrombolysis

Indexed keywords

ALTEPLASE; PLACEBO; PROUROKINASE;

ACUTE DISEASE; BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FUNCTIONAL ASSESSMENT; HEALTH PROGRAM; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; SCORING SYSTEM;

ALBERTA; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349512914     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00337.x     Document Type: Review

References (72)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. 1995, 333:1581-1587. Tissue plasminogen activator for acute ischemic stroke.
2. Hacke W, Kaste M, Bluhmki E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. 2008, 359:1317-1329. et al
3. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. 2000, 355:1670-1674.
4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. 1997, 28:2109-2118. The NINDS t-PA Stroke Study Group.
5. Patel SC, Levine SR, Tilley BC. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. 2001, 286:2830-2838. et al
6. Hacke W, Kaste M, Fieschi C. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). 1995, 274:1017-1025. et al
7. von Kummer R, Allen KL, Holle R. Acute stroke. 1997, 205:327-333. et al
8. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. 2001, 32:438-441.
9. Grotta JC, Chiu D, Lu M. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. 1999, 30:1528-1533. et al
10. Wardlaw JM, Dorman PJ, Lewis SC, Sandercock PA. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?. 1999, 67:651-653.
11. Pexman JH, Barber PA, Hill MD. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. 2001, 22:1534-1542. et al
12. Butcher KS, Lee SB, Parsons MW. Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. 2007, 38:941-947. et al
13. Muir KW, Baird-Gunning J, Walker L, Baird T, McCormick M, Coutts SB. Can the ischemic penumbra be identified on noncontrast CT of acute stroke?. 2007, 38:2485-2490.
14. Na DG, Kim EY, Ryoo JW. CT sign of brain swelling without concomitant parenchymal hypoattenuation. 2005, 235:992-1048. et al
15. Parsons MW, Pepper EM, Bateman GA, Wang Y, Levi CR. Identification of the penumbra and infarct core on hyperacute noncontrast and perfusion CT. 2007, 68:730-736.
16. Dzialowski I, Weber J, Doerfler A, Forsting M, von Kummer R. Brain tissue water uptake after middle cerebral artery occlusion assessed with CT. 2004, 14:42-48.
17. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats. II. Ischemic brain edema. 1980, 11:593-601.
18. Dzialowski I, Klotz E, Goericke S, Doerfler A, Forsting M, von Kummer R. Ischemic brain tissue water content. 2007, 243:720-726.
19. von Kummer R, Bourquain H, Bastianello S. Early prediction of irreversible brain damage after ischemic stroke at CT. 2001, 219:95-100. et al
20. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. 2005, 36:2110-2115.
21. Kalafut MA, Schriger DL, Saver JL, Starkman S. Detection of early CT signs of >1/3 middle cerebral artery infarctions. 2000, 31:1667-1671.
22. Silver B, Demaerschalk B, Merino JG. Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. 2001, 28:113-119. et al
23. von Kummer R. Effect of training in reading CT scans on patient selection for ECASS II. 1998, 51((Suppl. 3)):S50-2.
24. Hacke W, Kaste M, Fieschi C. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. 1998, 352:1245-1251. et al
25. Coutts SB, Demchuk AM, Barber PA. Interobserver variation of ASPECTS in real time. 2004, 35:e103-5. et al
26. Mak HK, Yau KK, Khong PL. Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS). 2003, 34:1194-1196. et al
27. Demaerschalk BM, Silver B, Wong E, Merino JG, Tamayo A, Hachinski V. ASPECT scoring to estimate >1/3 middle cerebral artery territory infarction. 2006, 33:200-204.
28. Coutts SB, Hill MD, Demchuk AM, Barber PA, Pexman JH, Buchan AM. ASPECTS reading requires training and experience. 2003, 34(10):e179. author reply e179
29. Pexman JH, Hill MD, Buchan AM. Hyperacute stroke. 2004, 25(3):516-518. et al, author reply
30. Wardlaw JM, Mielke O. Early signs of brain infarction at CT. 2005, 235:444-453.
31. Dzialowski I, Hill MD, Coutts SB. Extent of early ischemic changes on computed tomography (CT) before thrombolysis, prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. 2006, 37(4):973-978. et al
32. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. 2004, 35:151-156.
33. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hoover SL, Alexandrov AV. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion. 2008, 18:56-61.
34. Barber PA, Hill MD, Eliasziw M. Imaging of the brain in acute ischaemic stroke. 2005, 76:1528-1533. et al
35. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke. 2005, 172:1307-1312.
36. Weir NU, Pexman JH, Hill MD, Buchan AM. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA?. 2006, 67:516-518.
37. Hill MD, Rowley HA, Adler F. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. 2003, 34:1925-1931. et al
38. Furlan A, Higashida R, Wechsler L. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study. 1999, 282:2003-2011. et al
39. Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. 2006, 27:1612-1616.
40. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke. 2004, 35:904-911.
41. Khatri P, Hill MD, Palesch YY. Methodology of the Interventional Management of Stroke III Trial. 2008, 3:130-137. et al
42. Tanne D, Kasner SE, Demchuk AM. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice. 2002, 105:1679-1685. et al
43. Chalela JA, Kidwell CS, Nentwich LM. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke. 2007, 369:293-298. et al
44. Kimura K, Iguchi Y, Shibazaki K. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke. 2008, 39(8):2388-2391. et al
45. Schramm P, Schellinger PD, Klotz E. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. 2004, 35:1652-1658. et al
46. Lev MH, Segal AZ, Farkas J. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis. 2001, 32:2021-2028. et al
47. Camargo EC, Furie KL, Singhal AB. Acute brain infarct. 2007, 244:541-548. et al
48. Coutts SB, Lev MH, Eliasziw M. ASPECTS on CTA source images versus unenhanced CT. 2004, 35:2472-2476. et al
49. Baron JC. Mapping the ischaemic penumbra with PET. 1999, 9:193-201.
50. Coutts SB, Simon JE, Tomanek AI. Reliability of assessing percentage of diffusion-perfusion mismatch. 2003, 34:1681-1683. et al
51. Butcher K, Parsons M, Allport L. Rapid assessment of perfusion-diffusion mismatch. 2008, 39:75-81. et al
52. Lin K, Rapalino O, Lee B. Correlation of volumetric mismatch and mismatch of Alberta Stroke Program Early CT Scores on CT perfusion maps. 2009, 51:17-23. et al
53. Parsons MW, Pepper EM, Chan V. Perfusion computed tomography. 2005, 58:672-679. et al
54. Barber PA, Demchuk AM, Hill MD. The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change. 2004, 75:1426-1430. et al
55. Puetz V, Dzialowski I, Hill MD. Intracranial thrombus extent predicts functional outcome, final infarct size and hemorrhagic transformation in ischemic stroke. 2008, 3(4):230-236. et al
56. Torres-Mozqueda F, He J, Yeh IB. An acute ischemic stroke classification instrument that includes CT or MR angiography. 2008, 29:1111-1117. et al
57. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome. 2007, 38:967-973.
58. Saqqur M, Uchino K, Demchuk AM. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. 2007, 38:948-954. et al
59. Wunderlich MT, Goertler M, Postert T. Recanalization after intravenous thrombolysis. 2007, 68:1364-1368. et al
60. Lee KY, Han SW, Kim SH. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. 2007, 38:192-193. et al
61. Tan IY, Demchuk AM, Hopyan J. CT angiography clot burden score and collateral score. 2009, 30:525-531. et al
62. Marler JR, Tilley BC, Lu M. Early stroke treatment associated with better outcome. 2000, 55:1649-1655. et al
63. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. 1999, 30:287-292.
64. Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA " dot" sign. 2001, 32:84-88.
65. Tomsick TA, Brott TG, Olinger CP. Hyperdense middle cerebral artery. 1989, 31:312-315. et al
66. Sims JR, Rordorf G, Smith EE. Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. 2005, 26:246-251. et al
67. Lindsay P, Bayley M, McDonald A, Graham ID, Warner G, Phillips S. Toward a more effective approach to stroke. 2008, 178:1418-1425.
68. Hacke W, Donnan G, Fieschi C. Association of outcome with early stroke treatment. 2004, 363:768-774. et al
69. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. 1995, 26:2219-2221.
70. Schellinger PD. EPITHET. 2008, 7:286-287.
71. Puetz V, Sylaja PN, Coutts SB. Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. 2008, 39:2485-2490. et al
72. Handschu R, Garling A, Heuschmann PU, Kolominsky-Rabas PL, Erbguth F, Neundorfer B. Acute stroke management in the local general hospital. 2001, 32:866-870.